Back to search

National and Kapodistrian University of Athens

Διερεύνηση της αποτελεσματικότητας σχημάτων ινσουλινοθεραπείας στον ινσουλινοεξαρτώμενο σακχαρώδη διαβήτη, με τη χρήση υπολογιστικών μεθόδων

Abstract

dc:description

Αim of this study, was to evaluate the efficacy of the new long-acting insulin analog Glargine or Lantus. SUBJECTS AND STUDY METHODS: The sample consisted of 135 children, adolescents and young adults (79 boys and 56 girls) with type 1 diabetes who changed their basal insulin with the new analogue Glargine.72 of them were <18 years old and the remaining 63 were >18 years old. Subjects' mean age [+/-standard deviation (SD)]at diagnosis of diabetes was 8,6 +/- 4.5 yr and mean age just before the initiation of glargine therapy was 17,7 +/- 4.95 yr. Data were collected for baseline, just before the initiation of glargine and for the next 24 months after adding glargine. The patient decided to participate in this study, because the promotion for the flexibility and the effectiveness of the new analogue was a real challenge for them, as they wanted to achieve better glycemic control and a quality of life. The collected data included the HbA1c levels, the number of mild hypoglycemic episodes and also the frequency of nocturnal and severe hypoglycemias. The total daily insulin requirements and also the requirements for the short acting and basal insulin seperately. Other data collected were about the Body Mass Index, the number of basal insulin injections and the type of short acting insulin before meals. All these data were analysed just before the beginning of Lantus and for 2 years after the initiation of the new therapy. Also, This study examined the possible difference between these parameters in relation to the sex and different ages attempted to compare the short acting insulin types in order to find the better combination with insulin Lantus for better glycemic control. STATISTICAL ANALYSIS: Paired students’ t- test has been used to compare quantitative variables and Pearson x2 for the categorical variables, like the appearance of mild hypoglycemic episodes. The one way ANOVA test has been used for the comparison between the variables before in correlation with sex and age. The significance level was this of 5%. RESULTS ΗbA1c was significantly lower after initiation of treatment for the whole duration of the study compared to the pre glargine levels. Insulin requirements were significantly reduced at12 and 21 and 24 months after the initiation of the new therapy. HbA1c improvement was achieved with no significant increase of body mass index in young adults. On the contrary, there was an expected impact on the weight and of course the BMI, of children and adolescents, just because of rapidly developing at these ages. There was no difference in the number of mild, nocturnal or severe hypoglycemic episodes before and after glargine treatment. The results were different at the ages <18 years old, as there was observed significant difference at the frequency of mild, nocturnal and severe hypoglycemias, after the initiation of Glargine. Because of the low frequency of severe hypoglycemic cases, it is better to use more cases, so the results after the initiation of glargine will be more accurate. The patients who benefited the most regarding HbA1c improvement were those with 4 insulin injections (3 short/rapid acting and one middle or long acting insulin) before glargine initiation instead of 3, 5 or 2 injections. There was a significant reduction of the percentage of basal insulin and a significant increase of the short/rapid acting insulin in compared to the pre glargine levels and that was apparent in children and young adults also. The results were the same for both age groups. CONCLUSIONS: This retrospective study suggests that insulin glargine is effective as basal insulin, more effective as other long-acting insulins because it achieved better glycemic control in children, adolescents and young adults with T1D, as compared with the traditional basal insulins. At least once daily injection of glargine it is as effective as twice daily injections of other basal insulins, such as NPH, in improving glycemic control. The insulin glargine in combination with rapid acting analogues for the premeal insulins (lispro, aspart), benefits over the simple rapid acting insulins (Actrapid, Regular) in the effectiveness and flexibility of glycemic control.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2006

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Θυμέλλη, Ιωάννα
  • Thymelli, Ioanna

Subjects

dc:subject × 19

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/20947

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Θυμέλλη, Ιωάννα; Thymelli, Ioanna. Διερεύνηση της αποτελεσματικότητας σχημάτων ινσουλινοθεραπείας στον ινσουλινοεξαρτώμενο σακχαρώδη διαβήτη, με τη χρήση υπολογιστικών μεθόδων. National and Kapodistrian University of Athens, 2006. http://hdl.handle.net/10442/hedi/20947